Evidence Level:Resistant: D – Preclinical
Title:
Inhibiting Mitochondria Function By Bcl-2 Inhibitor Venetoclax and Complex I Inhibitor Iacs-010759 Eliminate Leukemia Cells in Pre-Clinical AML Models
Excerpt:Further, cells with BCL-2 overexpression were less sensitive to IACS-010759.
DOI:https://doi.org/10.1182/blood-2019-124494